L'Équipe médicale

Dr Benjamin Wyplosz, directeur médical

Benjamin Wyplosz

  • Docteur en médecine et docteur en sciences (PhD), habilité à diriger des recherches (HDR), spécialiste en médecine interne (DES), spécialiste en maladies infectieuses et tropicales (DESC).
  • Praticien hospitalier dans le service de maladies infectieuses et tropicales et responsable du Centre de vaccinations internationales du CHU Bicêtre de 2018 à 2023.
  • Consultant à Gustave Roussy (Villejuif) de 2021 à 2023.
  • Consultant en Pathologie infectieuse et tropicale à l'Institut Pasteur de Paris de 1999 à 2004, puis à partir de 2024.
  • Praticien en hospitalisation à domicile (AP-HP).
  • Membre du groupe Prévention/Vaccination de la SPILF

Dernières publications concernant uniquement les voyages et/ou la vaccination :

Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France. Saade A, Wyplosz B, Baldeyrou M, Paris C, Tattevin P, Janssen C; SPILF group “Vaccination et Prévention”.Infect Dis Now. 2024;54:104863. doi: 10.1016/j.idnow.2024.104863.

Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France. Paccoud O, Chamillard X, Kendjo E, Vinatier I, Surgers L, Magne D, Wyplosz B, Angoulvant A, Bouchaud O, Izri A, Matheron S, Houzé S, Thellier M, Ndour AP, Buffet P, Caumes E, Jauréguiberry S; French National Reference Center for Imported Malaria Study Group.Int J Infect Dis. 2023 ;137:144-148. doi: 10.1016/j.ijid.2023.10.018.
 

Within-host density and duration of colonization of travel-acquired multidrug-resistant Enterobacterales in untreated individuals. Cotto O, Armand-Lefèvre L, Matheron S, Ruppé E, Blanquart F; VOYAG-R study group. Clin Infect Dis. 2023. doi: 10.1093/cid/ciad369

Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the tropics. Rondinaud E, Clermont O, Petitjean M, Ruppé E, Esposito-Farèse M, Nazimoudine A; VOYAG-R Study Group; Coignard B, Matheron S, Andremont A, Denamur E, Armand-Lefevre L. J Travel Med. 2023;30. doi: 10.1093/jtm/taac141

Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study. Wyplosz B, Fernandes J, Sultan A, Roche N, Roubille F, Loubet P, Fougère B, Moulin B, Duhot D, Vainchtock A, Raguideau F, Lortet-Tieulent J, Blanc E, Moïsi J, Goussiaume G. Vaccine. 2022;40(33):4911-4921. doi: 10.1016/j.vaccine.2022.06.071.

Adults at risk of pneumococcal disease in France. Wyplosz B, Fernandes J, Goussiaume G, Moïsi J, Lortet-Tieulent J, Vainchtock A, Leboucher C, Raguideau F. Infect Dis Now. 2021;51(8):661-666. doi: 10.1016/j.idnow.2021.07.006

COVID-19 vaccination in patients suffering from respiratory diseases. Update of 25th June 2021.
Blanchard E, Ozier A, Janssen C, Wyplosz B, Andrejak C.Rev Mal Respir. 2021 Sep; 38(7):780-793. doi: 10.1016/j.rmr.2021.07.003.

Adults at risk of pneumococcal disease in France.
Wyplosz B, Fernandes J, Goussiaume G, Moïsi J, Lortet-Tieulent J, Vainchtock A, Leboucher C, Raguideau F.Infect Dis Now. 2021 Nov;51(8):661-666. doi: 10.1016/j.idnow.2021.07.006. Epub 2021 Jul 31.PMID: 34343722

COVID-19 vaccines: Frequently asked questions and updated answers.
Lefebvre M, Vignier N, Pitard B, Botelho-Nevers E, Wyplosz B, Cohen R, Epaulard O; SPILF Vaccination Prevention group.Infect Dis Now. 2021;51(4):319-333. doi: 10.1016/j.idnow.2021.02.007.
 

Persistence of Yellow Fever Immunization-Induced Antibodies in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Adler M, Lapierre V, Sakr R, Bourhis JH, Gachot B, Castilla-Llorente C, Wyplosz B. J Infect Dis. 2018 May 5;217(11):1844-1845. doi: 10.1093/infdis/jiy050.

Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics. Lorme F, Maataoui N, Rondinaud E, Esposito-Farèse M, Clermont O, Ruppe E, Arlet G, Genel N; VOYAG-R study group; Matheron S, Andremont A, Armand-Lefevre L. PLoS One. 2018 Dec 18;13(12):e0206909. doi: 10.1371/journal.pone.0206909

Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin. Bukreyeva I, Angoulvant A, Bendib I, Gagnard JC, Bourhis JH, Dargère S, Bonhomme J, Thellier M, Gachot B, Wyplosz B. Emerg Infect Dis. 2017;1039-1041. doi: 10.3201/eid2306.161825

A study of the immune response to yellow fever vaccine among infants previously immunized against measles. Goujon C, Gougeon ML, Tondeur L, Poirier B, Seffer V, Desprès P, Consigny PH, Vray M; study group. Vaccine. 2017;35(45):6166-6171. doi: 10.1016/j.vaccine.2017.09.047.

Comment vacciner plus de 500 malades à l'hôpital en moins de 2 ans et demi ? utilisez votre CVI!  Bukreyeva I, Tzara L, Derradji O, Gagnard JC, Escaut L, Vittecoq D, Wyplosz B. Med Mal Infect. 2016;46(4 Suppl 1):94.

Intention to vaccinate against influenza among health care workers caring for immunocompromised patients. Loulergue P, Kernéis S, Stern JB, Kassis-Chikani N, Derradji O, Escaut L, Launay O, Vittecoq D, Wyplosz B. Am J Infect Control. 2016;44(9):1080-2. doi: 10.1016/j.ajic.2016.02.030.
 
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics. Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S. Clin Infect Dis. 2015;61:593-600. doi: 10.1093/cid/civ333
 
Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013. Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E; French Artesunate Working Group. Emerg Infect Dis. 2015;21:804-12. doi: 10.3201/eid2105.141171
No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics? Wyplosz B, Leroy JP, Derradji O, Consigny PH. J Travel Med. 2015 Mar-Apr;22(2):140-1. doi: 10.1111/jtm.12173

Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation. Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D, Consigny PH; GEVACCIM. Am J Transplant. 2013 Sep;13(9):2458-61. doi: 10.1111/ajt.12338

Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study. Kernéis S, Launay O, Ancelle T, Iordache L, Naneix-Laroche V, Méchaï F, Fehr T, Leroy JP, Issartel B, Dunand J, van der Vliet D, Wyplosz B, Consigny PH, Hanslik T. Arthritis Care Res (Hoboken). 2013;6:1522-8. doi: 10.1002/acr.22021

Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey. Loulergue P, Fonteneau L, Armengaud JB, Momcilovic S, Levy-Brühl D, Launay O, Guthmann JP; Studyvax survey group. Vaccine. 2013;31:2835-8. doi: 10.1016/j.vaccine.2013.04.004
 
Pneumococcal infections and vaccination in patients with systemic autoimmune and/or inflammatory diseases. Duchet-Niedziolka P, Hanslik T, Aouba A, Le Guern V, Guillevin L, Launay O; Groupe GEVACCIM. Presse Med. 2009;38:243-50. doi: 10.1016/j.lpm.2008.10.010
 
Vaccination in patients with systemic diseases. Hanslik T, Niedziolka P, Kernéis S, Launay O; Groupe GEVACCIM. Presse Med. 2009;38:235-42. doi: 10.1016/j.lpm.2008.10.011.
 
Insuffisance rénale et voyage en pays tropical. Wyplosz B. Renif'mag. Juin 2013
 

Les vaccinations chez les adultes traités pour un cancer. Wyplosz B, Loulergue P. Reflexions en médecine oncologique. Janvier 2011

Vaccinations du voyageur adulte transplanté d’organes (à l’exclusion des receveurs de cellules souches hématopoïétiques).Wyplosz B, Van der Vliet D, Consigny PH, Calmus Y, Mamzer-Bruneel MF, Guillemain R, Malvy D, Samuel D, Vittecoq D, Launay O; pour le groupe d'étude de la vaccination des immunodéprimés (GEVACCIM). Med Mal Infect. 2009 Apr;39(4):225-33. doi: 10.1016/j.medmal.2008.11.006

Prévention du risque chez le voyageur d'entreprise. Wyplosz B, Gachot B. Revue Ressources humaines et Management. 2006.

Imported tickborne relapsing fever, France. Wyplosz B, Mihaila-Amrouche L, Baixench MT, Bigel ML, Berardi-Grassias L, Fontaine C, Hornstein M, Izri A, Baranton G, Postic D. Emerg Infect Dis. 2005;11:1801-3. doi: 10.3201/eid1111.050616